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Abstract
Background: Besides maintaining intracellular glutathione stores, gamma-glutamyltransferase(GGT) generates reactive
oxygen species and activates NFkB, a redox-sensitive transcription factor key in the induction of Tissue Factor (TF) gene
expression, the principal initiator of the clotting cascade. Thus, GGT might be involved in TF-mediated coagulation
processes, an assumption untested insofar.
Methods: Experiments were run with either equine, enzymatically active GGT or human recombinant (hr) GGT, a
wheat germ-derived protein enzymatically inert because of missing post-translational glycosylation. TF Procoagulant
Activity (PCA, one-stage clotting assay), TF antigen(ELISA) and TFmRNA(real-time PCR) were assessed in unpooled
human peripheral blood mononuclear cell(PBMC) suspensions obtained from healthy donors through discontinuous
Ficoll/Hystopaque density gradient.
Results: Equine GGT increased PCA, an effect insensitive to GGT inhibition by acivicin suggesting mechanisms
independent of its enzymatic activity, a possibility confirmed by the maintained stimulation in response to hrGGT, an
enzymatically inactive molecule. Endotoxin(LPS) contamination of GGT preparations was excluded by heat inactivation
studies and direct determination(LAL method) of LPS concentrations <0.1 ng/mL practically devoid of procoagulant
effect. Inhibition by anti-GGT antibodies corroborated that conclusion. Upregulation by hrGGT of TF antigen and mRNA
and its downregulation by BAY-11-7082, a NFkB inhibitor, and N-acetyl-L-cysteine, an antioxidant, was consistent with a
NFkB-driven, redox-sensitive transcriptional site of action.
Conclusions: GGT upregulates TF expression independent of its enzymatic activity, a cytokine-like behaviour mediated
by NFκB activation, a mechanism contributing to promote acute thrombotic events, a possibility in need, however, of
further evaluation.
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tide⁄amino acid 5-glutamyl transferase; EC 2.3.2.2], a
member of the structural superfamily of the N-terminal
nucleophilic hydrolases expressed by a wide number of
cell types [1] including circulating monocytes [2, 3],
hydrolyzes extracellular glutathione (GSH) to provide
cysteine for its intracellular re-synthesis. Along with its
pivotal role in that antioxidant biological process [1],
however, GGT also generates reactive oxygen species
(ROS) [4] and activates NFkB [5, 6], a redox-sensitive
transcription factor [7] key in Tissue Factor (TF) gene
expression [8], a major regulator of haemostasis and
thrombosis [8, 9]. Therefore, deductive reasoning makes
it plausible to hypothesize a cross-talk between GGT
and TF, a possibility consistent with the highly consist-
ent epidemiological association of circulating GGT levels
with acute coronary events (see [10] for a review), a
pathological process favoured by TF (see [11] for a
review). The assumption, corroborated by recent reports
of enzymatically active protein in human atheromatous
plaques [12], requires, however, to document a mechan-
istic link between GGT and TF for which at the moment
no evidence is available.
Aims
On the basis of that background, our aim was to evalu-
ate the relationship between GGT and TF expression in
human peripheral blood mononuclear cell (PBMC)s, a
cell preparation capable of rapid TF induction in
response to various proinflammatory stimuli [8].
Methods
Chemicals and standards
Unless stated otherwise, all reagents were from Sigma,
Milano, Italy.
Cell isolation and culture
Human PBMC suspensions were obtained from unpooled
buffy coats left over from blood bank draws taken from
healthy donors with the approval of the local ethics
committee of the Azienda Ospedaliero Universitaria
Pisana, kept at room temperature and utilized within a
maximum of 4 h from withdrawal. As detailed elsewhere
[13], leukocytes were isolated from fresh buffy coats
diluted 1:1 with sodium citrate 0.38 % in saline solution,
mixed gently with 0.5 volume of 2 % Dextran T500 and
left for 40 min for erythrocyte sedimentation. The
leukocyte-rich supernatant was recovered and centrifuged
for 10 min at 200xg. The pellet was resuspended in 30 mL
of sodium citrate solution, layered over 15 mL of Ficoll-
Hypaque and centrifuged for 30 min at 400xg at 20 °C.
The PBMC-rich ring (3×106 cells/mL) was recovered,
washed twice in sodium citrate 0.38 % and resuspended in
polypropylene tubes in no glucose RPMI 1640 medium
supplemented with 100 U/mL penicillin-streptomycin.
All reagents and solutions used for cell isolation
and cultures were prepared with endotoxin-free water
and glassware was rendered endotoxin-free by expos-
ure to high temperature. Drugs were kept in stock
solution and diluted in serum-free RPMI at the
appropriate concentrations immediately before use.
Cell viability, as assessed by dimethyl thiazolyl diphenyl
tetrazolium (MTT), was verified (>85 % of viable cells)
throughout all experimental phases.
The final PBMC preparations typically contain 25–35 %
monocytes, negligible proportions of neutrophils (<5 %)
and 65–75 % lymphocytes, a cell line with some but lim-
ited procoagulant potential [14]. Moreover, interferences
from contaminating platelets [15] were excluded by absent
procoagulant activity in clotting assays carried out in
PBMC-free preparations as verified in pilot experiments,
so that stimulated TF expression should be considered by
and large a result of activated monocytes.
GGT
GGT experiments were carried out by using either
equine, enzymatically active GGT purified according to
already described procedures [16], or human recombi-
nant(hr)GGT (Abnova, Taipei, Taiwan), a protein synthe-
sized by wheat germ eukaryotic translational apparatuses
in which lack of post-translational glycosylation forbids
the generation of enzymatically active molecules [17, 18].
Confirming that assumption, GSH as measured by stand-
ard methods [19] was not cleaved by hrGGT in contrast
with the hydrolysis induced by equine GGT, an effect this
latter abolished by acivicin (10−4 M), a glutamate analogue
with potent, non competitive GGT inhibiting properties
[20], inactive on hrGGT (Fig. 1).
To exclude interferences from endotoxin (LPS)
contamination [21], experiments were carried out with
GGT preparations boiled for 30 min before their
addition to PBMCs, a procedure expected to abrogate
the biological effect of GGT but not the procoagulant
power of heat-resistant LPS [21]. In the light of heat
sensitivity of some LPS strains [22], endotoxin concen-
tration was also measured in hrGGT-primed cultures by
LAL (Limulus Amebocyte Lysate) chromogenic endpoint
assay (Hycult Biotech, Uden, The Netherlands) [23] and
the procoagulant effect of contaminant LPS levels was
then tested in quiescent PBMCs. Finally, we assessed the
effect of hrGGT-inhibition by an anti-GGT polyclonal
antibody (Abnova, Taipei, Taiwan), 2.5 μg/mL, a concen-
tration chosen according to preliminary concentration-
response experiments (not shown), as compared with
the appropriate isotype IgG control.
The role of NFkB was indirectly assessed by using
BAY-11-7082 (10−5M), a validated NFkB inhibitor [24],
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as well as N-acetyl-L-cysteine (NAC, 10−3M), an antioxi-
dant with inhibitory effect on NFkB [25].
Experimental methods
TF Procoagulant Activity (PCA)
PCA was assessed by a one-stage clotting time test in
PBMCs disrupted by three freeze–thaw cycles as reported
previously [26]. Disrupted cells (100 μL) were mixed with
100 μL of normal human plasma at 37 °C, adding 100 μl
of 25 mM CaCl2 at 37 °C. Time to clot formation was
recorded and values converted to arbitrary units (AU) by
comparison with a standard human brain TF calibration
curve covering clotting times from 20 to 600 s. The stand-
ard TF preparation was arbitrarily assigned a value of
1000 AU/mL and a representative conversion of clotting
times to AU is as follows: 100 AU-21 s, 10 AU-40s,
1 AU-82 s, 0.1-187 s, 0.01 AU-375 s, 0.001 AU-600 s.
“Baseline” values were defined as clotting times above
375 s (0.01 AU) and refer to quiescent, non activated,
untreated PBMCs. Experiments were run in triplicate
and averaged.
TF antigen(ag)
Cells were disrupted by three repeated freeze–thaw cycles
and debris pelleted by centrifugation at 100xg for 1 h at
4 °C and supernatants used for ELISA according to
manufacturer’s instructions (Imubind TF kit Sekisui Diag-
nostics, West Malling, United Kingdom). Within and
between assay variability was 3.5 and 5.5 %, respectively.
TF mRNA
Total RNA was extracted from PBMCs using the RNeasy
mini kit (Qiagen, Hilden, Germany). RNA concentration
and purity were determined by optical density measurement
via Nanodrop (Thermo Fisher Scientific, Wilmington,
Delaware USA). A mixture of 0.5 ng total RNA per sample
was retro-transcribed with random primer-oligodT into
complementary DNA (cDNA) using the Quantitect Reverse
Transcription Kit (Qiagen, Hilden, Germany). The retro-
transcription cycle was performed at 25 °C for 5 min, 42 °C
for 30 min and 95 °C for 3 min. RealTime-PCR was carried
out in a iQ5 Real Time PCR System and SsoAdvanced Sybr
Green Supermix (Bio-Rad Laboratories, Hercules, CA) was
employed on the basis of the manufacturer’s conditions:
95 °C, 30s; 40 cycles 95 °C, 5 s, 60 °C, 15 s;a final melting
protocol with ramping from 65 °C to 95 °C with 0,5 °C
increments of 5 s was performed. The primers sequence for
RealTime-PCR were: TF, sense 5’-TTGGCAAGGACTT
AATTTATACAC-3’, antisense 5’-CTGTTCGGGAGGGA
ATCAC-3’; GAPDH, sense: 5’-CCCTTCATTGACCTCA
ACTACATG-3’ and antisense: 5’-TGGGATTTCCATTGA
TGACAAGC-3’ (Invitrogen, Monza, Italy). All samples
were analysed in duplicate and averaged. The relative
expression of the target gene was normalized to the level of
GAPDH in the same cDNA.
PCA and TFag were assayed after a 18 h incubation
period while TFmRNA was evaluated after a 2 h interval.
BAY 10–772, NAC and anti-GGT polyclonal antibody
were added 30 min prior to GGT stimulation.
PCA, ELISA and Q-PCR results in each control and
experimental group were all generated from suspensions
containing equal number of cells (3×106 PBMCs/mL).
Statistics
Statistical differences were tested by Mann–Whitney
test. Data were reported as means ± SD unless otherwise
reported. A two-tailed p-level <0.05 was the threshold
for statistical significance.
Results
GGT stimulates TF expression independent of its
enzymatic properties
Equine GGT (100 mU/mL) stimulated TF PCA, an
effect insensitive to GGT inhibition by acivicin (10−4M)
(Fig. 2). Incubation of the samples with an antihuman
TF antibody (30 μg/mL; IgG, American Diagnostica)
abolished more than 95 % of the PCA indicating its
dependence upon TF (data not shown).
hrGGT, an enzymatically inactive protein induced a
graded, concentration-dependent PCA stimulation
without evidence of a plateau (Fig. 3, left panel). As a
comparison, PCA in response to the peak hrGGT
concentration (1.0 μg/mL) used in those studies was in
the range obtained under identical experimental condi-
tions by a well characterized procoagulant agonist such
as LPS at a standard concentration of 0.1 μg/mL (from
0.01 ± 0.008 to 1.12 ± 0.2 AU) [13].
Fig. 1 Absent hydrolytic effect of hrGGT (0.5 μg/mL) in contrast with
the complete GSH cleavage obtained by equine GGT (100 mU/mL)
reversed by acivicin (ACI, 10−4M), an irreversible GGT inhibitor [20]
inactive on hrGGT. Results from a single experimental set after
overnight GSH incubation and expressed as percent changes from
control. GSH was measured according to standard methods [19]
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Taking into account its equieffectiveness to natural
GGT, 100 mU/mL, all further studies were carried out
with hrGGT, 0.5 μg/mL, and the time course of its effect
on PCA is reported in Fig. 3, right panel.
LPS contamination does not explain GGT-induced TF
expression
Heat inactivation abrogated the effect of either natural
GGT (Fig. 2) or hrGGT (data not shown).
LPS determination in hrGGT preparations averaged
0.07 ± 0.02 ng/mL (n = 4 replicates), a concentration that
did not affect baseline PCA to a statistically significant
extent quite in contrast with hrGGT (Fig. 4, left panel).
hrGGT-induced procoagulant responses were down-
regulated by an anti-GGT IgG polyclonal antibody
(Fig. 4, right panel).
hrGGT induces TF transcription by activating NFkB and
increasing ROS generation
hrGGT, 0.5 μg/mL, induced an increase in both TFag
and mRNA (Fig. 5, left and right panel). BAY-11-7082
(10−5M) inhibited both GGT-stimulated TF protein and
activity (Fig. 6, left and right panel), an inhibitory effect
on PCA shared by NAC (10−3M, from 0.35 ± 0.07 to
0.09 ± 0.01, p < 0.001, n = 7).
Discussion
Discussion of the effects of GGT on TF expression
needs some preliminary comments about endotoxin
contamination, an important concern in the light of the
frequent pollution by that bacterial product of cell cul-
tures even if grown in carefully controlled experimental
conditions [22]. However, three orders of considerations
make that possibility unlikely. First, GGT-induced PCA
was abrogated by heat, a procedure generally ineffective
on heat-resistant LPS [21]. Secondly, LPS levels in our
preparation were less than <0.1 ng/mL, a concentration
with a minor, if any, procoagulant action and certainly
far less than that of GGT, a behaviour excluding an
important role for heat-sensitive LPS strains [22].
Thirdly, inhibition of TF activity by an anti-GGT anti-
body provided additional proof of the specificity of the
procoagulant response to hrGGT.
Having this background in mind, the main and original
outcome of this study was the demonstration of the
procoagulant properties of GGT and their independence
from the enzymatic action of the molecule. That latter,
quite intriguing conclusion is based upon the insensitiv-
ity of natural GGT-stimulated PCA to acivicin, a highly
specific GGT inhibitor [20] and, more importantly, by
the maintained procoagulant effect of hrGGT, a wheat
germ-derived protein devoid of enzymatic activity
because of a missing post-translational glycosylation ap-
paratus [17, 18], an assumption fully verified by our
GSH hydrolysis experiments reported in Fig. 1. Thus,
hrGGT induced a concentration-dependent procoagu-
lant effect, increased TFag and upregulated mRNA, a
behaviour this latter showing that GGT-induced TF gene
transcription is an early event since our mRNA assays
Fig. 2 PCA stimulation by equine GGT (100 mU/mL), an effect
insensitive to acivicin (ACI, 10−4), a GGT inhibitor [20], and abolished
by heat inactivation of the enzyme. Means ± SD, n = 6, * p < 0.001
vs baseline. Baseline PCA refer to values ≤0.01 AU
Fig. 3 Left panel: Concentration-dependent increase in PCA in response to hrGGT, an enzymatically inactive protein. Means ± SD, n = 7, $ p < 0.05
and * p < 0.001 vs baseline (B). Right panel: Time course of PCA in PBMCs stimulated by hrGGT, 0.5 μg/mL (■), as compared to quiescent
cell preparations (▲). Means, n = 4. Baseline PCA refer to values ≤0.01 AU
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were obtained after only 2 h of exposure to the mol-
ecule, quite similar in this regard to the response
induced by unrelated cytokines and inflammatory ago-
nists (e.g. [27]). However, additional studies are needed
to evaluate the pattern of GGT-induced gene expression
over a longer time course and the reader should also be
aware that our PCR procedure based upon the use of
GAPDH as a single and quite variable reference gene
may present some technical limitations [28, 29]. More-
over, GGT-induced TF gene transcription was likely
located at the level of NFkB activation given the inhibi-
tory effect of BAY-10-772, a pharmacological antagonist
[24] of that crucial controller of redox stimuli conver-
ging upon TF gene [7, 8]. The conclusion was strength-
ened by the negative modulation of PCA exerted by
NAC, a sulfhydryl-group donor that, by increasing the
antioxidant thiol pool and scavenging the excess of
intracellular ROS, downregulates NFkB [25]. Therefore,
our data, besides constituting, to the best of our know-
ledge, the first demonstration of a direct TF procoagulant
effect of GGT, also provide consistent, albeit admittedly
indirect, evidence for increased ROS production and
NFkB activation as the pathophysiological mechanism
linking GGT to TF expression in PBMCs.
That GGT might induce ROS generation is a concept
dating back to two decades ago or so when Glass and
Stark showed oxidative damage of cell surface proteins
and membrane lipids as a consequence of GSH cleavage
by GGT inducing auto-oxidation of the sulfur via a
Fenton reaction resulting in the iron–dependent produc-
tion of oxygen radicals [30]. However, that mechanism,
which requires an enzymatically functional GGT
molecule, cannot evidently apply to our data. Rather,
direct, non enzymatic TF stimulation is closely conson-
ant with similar results obtained in evaluating the role of
the GGT as a bone resorbing factor [31]. The data open
obvious questions about the GGT-operated signal trans-
duction pathways upstream NFkB activation including
the mechanisms allowing membrane permeation of the
exogenous protein and the interaction with its intracellular
Fig. 4 Left panel: Procoagulant effect of LPS concentrations in the contaminant range (0.1 ng/mL) relative to baseline values and hrGGT-primed
values. Means ± SD, n = 3, *p < 0.001 vs LPS. Right panel: Inhibition of hrGGT(0.5 μg/mL)-stimulated PCA by a specific anti-hrGGT polyclonal IgG
antibody (Ab, 2.5 μg/mL). Means ± SD, n = 7, *p < 0.001 vs hrGGT+ IgG isotype control. Baseline PCA refer to values ≤0.01 AU
Fig. 5 Stimulation by hrGGT (0.5 μg/mL) of TFag (left panel) and TFmRNA (right panel). Means ± SD, n = 13 and n = 9 each, *p < 0.001 vs baseline
Scalise et al. Thrombosis Journal  (2016) 14:45 Page 5 of 8
targets. Although our results cannot answer this specific
point, one might conjecture of a specific but insofar not
identified GGT-receptor or lipid-driven endocytosis [32].
Perhaps, some role may play a chemokine-like CX3C motif
contained in the GGT molecule [33] or exogenous GGT
might mimick cytokine-like activities of GGT-related pro-
teins produced by genes different from the GGT1 [34]. For
example, the GGT2 gene located close to the GGT1
chromosomal region seems to encode for a full length, en-
zymatically inactive protein, not localized to the plasma
membrane [35] and, according to some Authors, involved
in redox modulation [36]. It might also be possible to envis-
age protein-protein interactions leading to the expression
of other procoagulant cytokines. Additional unresolved
questions to be addressed in future studies regard an
understanding of how the enzymatic and non-enzymatic
activity of GGT may complement each other as well as the
role of circulating GGT levels in the activation of the TF
procoagulant pathway.
The data reported in this study may have pathophysio-
logical and clinical relevance. In fact, previous experi-
ments have shown upregulated GGT transcription in
response to NADPH oxidase-mediated ROS generation
[37] as well as to agents endowed with TF-stimulating
properties [8] such as Tumor Necrosis Factor(TNF)-
alpha [38] and phorbol esters [39]. Moreover, mono-
cytes, a cell line harbouring GGT [2, 3], have recently
been shown to release a GGT fraction when exposed to
LPS [40], a product of Gram-negative bacteria that initi-
ates the pathogen-induced inflammatory response [41]
of which activation of coagulation is a prominent com-
ponent [9]. In that framework, thus, it is conceivable to
hypothesize a vicious circle by which circulating or
within-plaque [12, 40] GGT stimulates TF expression,
and plaque-derived cytokines induce procoagulant GGT
expression [38]. Both arms of this self-reverberating
mechanism hinging around NFkB activation [42] may
amplify the pro-thrombotic potential of vulnerable
atheromatous plaques possibly in synergism with TF
expressed by activated B- and T-lymphocytes [14, 43], a
tempting but at the moment only speculative hypothesis
worth being pursued in future studies.
Conclusions
Our data provide the first evidence of a procoagulant
action of GGT, a result that adds to the long [8] and
enlarging (e.g. [44, 45]) list of TF-inducing agents acting
through NFkB activation. In showing the independence
of that effect from its enzymatic activity, the data raise
the issue of the proinflammatory and prothrombotic
potential of GGT as a cytokine-like protein. However,
further work is needed to understand more precisely the
extent to which in-vitro data can be transferred to in-vivo
conditions and the possible pathophysiological importance
of this mechanism in cardiovascular risk modulation.
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